|20th November 2020||Garo H Armen||4,049||Grant/award etc.||$3.65||$14,778.85|
|6th November 2020||Garo H Armen||3,869||Grant/award etc.||$3.82||$14,779.58|
|23rd October 2020||Garo H Armen||3,751||Grant/award etc.||$3.94||$14,778.94|
|9th October 2020||Garo H Armen||3,397||Grant/award etc.||$4.35||$14,776.95|
|25th September 2020||Garo H Armen||3,676||Grant/award etc.||$4.02||$14,777.52|
|11th September 2020||Garo H Armen||2,962||Grant/award etc.||$4.99||$14,780.38|
|28th August 2020||Garo H Armen||3,452||Grant/award etc.||$4.28||$14,774.56|
|14th August 2020||Garo H Armen||3,984||Grant/award etc.||$3.71||$14,780.64|
|31st July 2020||Garo H Armen||4,861||Grant/award etc.||$3.04||$14,777.44|
|17th July 2020||Garo H Armen||4,105||Grant/award etc.||$3.60||$14,778.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
Agenus, Inc. engages in the development and commercialization of technologies to treat cancers and infectious diseases. The company was founded by Garo H. Armen and Pramod K. Srivastava in March 1994 and is headquartered in Lexington, MA.